Time to move. See you all on Bluesky: @helink.bsky.social
Let's work on getting our respective institutions and our colleagues to move as well. There is an exponential increase in members on Bluesky!!
https://t.co/KZKb8MYzve
Listen back to @BBCRadio4's #TheBriefingRoom to hear ICR’s Director of the Centre for Cancer Drug Discovery, Dr Olivia Rossanese @TEMT_ICR talk about preventing treatment resistance, targeted therapies, and what the future holds for cancer drugs ⤵️
🎙 https://t.co/9xANrcsoX7
Interested in H3K4 methylation. Then, Hua (now at Peking University) and Kristian recently shared their thoughts in a review in Trends in Cell Biology: 'Roles of H3K4 methylation in biology and disease'.
https://t.co/KcAE0uMJFN
👑We're so proud to receive a #QAPrize from Her Majesty The Queen today for our #BreastCancer research.
Read more about the special event 👇
https://t.co/VEdvwquXD6
Very excited to see a very big part of my PhD work @HelinLab out in @embojournal in my first first-author paper!
Massive thanks to all co-authors, and especially @AliaksandraR
If you want to learn more about chromatin remodeling complex NURF and it’s role in AML ⬇️
🏆We’re honoured to have been granted a Queen’s Anniversary Prize👑 (@QAPrizes), the highest national honour in UK further and higher education for our innovative work in #BreastCancer.
Find out more about the #QAPrize👇
https://t.co/QNMxiVmW9H
3) We also show a critical role for NSD1 in regulating cell fate transitions and transcriptional programs perturbed in Sotos syndrome.
Have a look at the paper and let us know what you think!
1) Interested in NSD1, Sotos syndrome and how H3K36 methylation regulates transcription? If so, please have a look at our new paper, spearheaded by Zhen Sun @zhensun24, now a postdoc in @SawyersLabMSKCC. https://t.co/xAoERBr0hy
2) We show that NSD1 both has catalytic dependent and independent roles in regulating transcription, that NSD1/H3K36me2 are enriched at enhancers, that NSD1 promotes enhancer activity and RNA Pol II pause release.
Join one of the world's leading centres for cancer #DrugDiscovery!
We're making a significant investment in our Division of #CancerTherapeutics with the appointment of five new senior Faculty. Find out more about the new roles here ⬇
https://t.co/bFCKI6JOEU
#ScienceJob
Position for a talented scientist to continue their work in Hematology/Leukemia Research available in our lab. Either at postdoc, senior scientific officer or staff scientist level. Please see advertisements below.
https://t.co/OhfrkcdLd4
Position for a talented scientist to continue their work in Hematology/Leukemia Research available in our lab. Either at postdoc, senior scientific officer or staff scientist level. Please see advertisements below.
https://t.co/ronjV9oCFz
https://t.co/fNbnvMB2Ei
Interested in epigenetics and the potential function of histone modifications? If so, Hua Wang in our lab has done some beautiful work in defining a role of H3K4me3!! Check out the paper - published today.
https://t.co/fhmOxiSfxf
Are you interested in how chromatin regulation affects cell phenotype and drives cancer? We have an open postdoc position in our new group @ICR_London. Join us in central London! https://t.co/miZdaTy75t
Are you into Epigenetics and/or interested in disease, we have a number of postdoc positions available in our lab located in central London. Excellent colleagues, cool science, check out the opportunity.
https://t.co/GHHk6hxPJk
Are you into Epigenetics and/or interested in disease, we have a number of postdoc positions available in our lab located in central London. Excellent colleagues, cool science, check out the opportunity.
https://t.co/GHHk6hxPJk